ID

28998

Beskrivning

A phase IV, open, multicentre study to assess the immunogenicity and reactogenicity of GlaxoSmithKline Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix hexa) given as a booster at 18-24 months of age to pre-term children who have received a three-dose primary immunization course with the same vaccine in study 217744/090.

Nyckelord

Versioner (1)
  1. 2018-02-20 2018-02-20 -
Rättsinnehavare

GlaxoSmithKline (GSK)

Uppladdad den

20 februari 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix-hexa) Study ID: 101518

Engelsk

Swelling assessment No.2

2 Formulär  
Report of physical examination and case clinical description
Beskrivning

Report of physical examination and case clinical description

Alias
UMLS CUI-1
C0031809
Date of physical examination
Beskrivning

Date

Datatyp

date

Alias
UMLS CUI [1]
C0011008
Was the examination performed by a member of study personnel during the extensive swelling period :
Beskrivning

Examiner

Datatyp

boolean

Alias
UMLS CUI [1]
C0025082
Date when the swelling was first considered to be extensive:
Beskrivning

Date of first extensive swelling

Datatyp

date

Alias
UMLS CUI [1,1]
C0038999
UMLS CUI [1,2]
C2700396
UMLS CUI [1,3]
C0205231
UMLS CUI [1,4]
C0011008
If occurring within 24 hours after vaccination, please specify how long after vaccination:
Beskrivning

Date of fist extensive swelling

Datatyp

integer

Måttenheter
  • hours
Alias
UMLS CUI [1,1]
C0038999
UMLS CUI [1,2]
C2700396
UMLS CUI [1,3]
C0205231
UMLS CUI [1,4]
C0011008
hours
Please give a clinical description of the observed extensive swelling, including a description of the joint involved and specific associated symptoms. Please mention also eventual diagnostic(s)
Beskrivning

Swelling case description

Datatyp

text

Alias
UMLS CUI [1,1]
C0449437
UMLS CUI [1,2]
C0678257
UMLS CUI [1,3]
C0038999
Tillbaka till toppen

Similar models

Swelling assessment No.2

2 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Date
Item
Date of physical examination
date
C0011008 (UMLS CUI [1])
Examiner
Item
Was the examination performed by a member of study personnel during the extensive swelling period :
boolean
C0025082 (UMLS CUI [1])
Date of first extensive swelling
Item
Date when the swelling was first considered to be extensive:
date
C0038999 (UMLS CUI [1,1])
C2700396 (UMLS CUI [1,2])
C0205231 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Date of fist extensive swelling
Item
If occurring within 24 hours after vaccination, please specify how long after vaccination:
integer
C0038999 (UMLS CUI [1,1])
C2700396 (UMLS CUI [1,2])
C0205231 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Swelling case description
Item
Please give a clinical description of the observed extensive swelling, including a description of the joint involved and specific associated symptoms. Please mention also eventual diagnostic(s)
text
C0449437 (UMLS CUI [1,1])
C0678257 (UMLS CUI [1,2])
C0038999 (UMLS CUI [1,3])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial